Evidence map›Paper›PMID 25646796›Full record

ArticlePLoS neglected tropical diseases2015

Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia.

Karina Mondragon-Shem, Waleed S Al-Salem, Louise Kelly-Hope, Maha Abdeladhim, Mohammed H Al-Zahrani, Jesus G Valenzuela, Alvaro Acosta-Serrano

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Interventions for American cutaneous and mucocutaneous leishmaniasis.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Article
  3. Human sand fly challenge elicits saliva-specific innate and TbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Molecular identification ofJournal of Taibah University Medical Sciences · 2023
    Article
  6. Review
  7. Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  8. African health sciences · 2022
    Review
  9. Vaccination in Leishmaniasis: A Review Article.Iranian biomedical journal · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.Frontiers in cellular and infection microbiology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Karina Mondragon-ShemDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Waleed S Al-SalemDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Department of Vector Borne Diseases, Saudi Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Louise Kelly-HopeDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Maha AbdeladhimVector Molecular Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Mohammed H Al-ZahraniDepartment of Vector Borne Diseases, Saudi Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Jesus G ValenzuelaVector Molecular Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Alvaro Acosta-SerranoDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine · GBNational Institutes of Health · USMinistry of Health · SA

Funding

Molecular approaches to understand vector-host and vector-pathogen interactionsZIAAI000932 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI VALENZUELA, JESUS · 2009 to 2025
$23.1M
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundThe sandfly Phlebotomus papatasi is the vector of Leishmania major, the main causative agent of Old World cutaneous leishmaniasis (CL) in Saudi Arabia. Sandflies inject saliva while feeding and the salivary protein PpSP32 was previously shown to be a biomarker for bite exposure. Here we used recombinant PpSP32 to evaluate human exposure to Ph. papatasi bites, and study the association between antibody response to saliva and CL in endemic areas in Saudi Arabia. METHODOLOGY/PRINCIPAL

findingsIn this observational study, anti-PpSP32 antibodies, as indicators of exposure to sandfly bites, were measured in sera from healthy individuals and patients from endemic regions in Saudi Arabia with active and cured CL. Ph. papatasi was identified as the primary CL vector in the study area. Anti-PpSP32 antibody levels were significantly higher in CL patients presenting active infections from all geographical regions compared to CL cured and healthy individuals. Furthermore, higher anti-PpSP32 antibody levels correlated with the prevalence and type of CL lesions (nodular vs. papular) observed in patients, especially non-local construction workers.

conclusionsOur findings suggest a possible correlation between the type of immunity generated by the exposure to sandfly bites and disease outcome.

Indexed as

AdolescentAdultAnimalsAntibodies, ProtozoanAntibody FormationCell LineFemaleHumansInsect Bites and StingsInsect VectorsLeishmania majorLeishmaniasis, CutaneousMaleMiddle AgedPhlebotomusPrognosisAntibodies, ProtozoanSalivary Proteins and Peptides

Identifiers

PMID25646796
PMCPMC4315490
OpenAlexW2010920685

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.